A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)
Author / Organization: Jaume Capdevila, Virginia Pubul, Urbano Anido, Thomas Walter, Javier Molina-Cerrillo, Teresa Alonso-Gordoa, Rocio Garcia-Carbonero, Maria San-Roman-Gil, Belen Llana, Paula Jimenez-Fonseca, Marta Benavent Viñuales, Catherine Ansquer, Eric Baudin, Come Lepage, Maribel del Olmo-García, José Carlos Ruffinelli, Amandine Beron, Magalie Haissaguerre, Emmanuel Deshayes, David Taïeb, Sergio Baldari, Maddalena Sansovini, Sara Cingarlini, Angelina Filice, Francesco Panzuto, Rosa Álvarez-Álvarez, Laurence Lousberg, Frank Aboubakar Nana, Jorge Hernando, Alejando García-Álvarez, Amparo García-Burillo, Guillermo Villacampa, Timon Vandamme, Nicola Fazio, Alice Durand
| File Format | PDF (Portable Document Format) |
|---|---|
| Publication Year | 2025 |
| Source Host |
HAL Open Science
(hal.science)
|
| License / Terms | Open Access / Creative Commons |
Ready for Immediate Access
Your selected document is ready for instant access with zero mandatory waiting period.